coronavirus main proteinase 3clpro structure: basis design anti-sars drugs 
novel coronavirus identified causative agent severe acute respiratory syndrome sars viral main proteinase m-pro also called 3clpro controls activities coronavirus replication complex attractive target therapy determined crystal structures human coronavirus strain 229e m-pro inhibitor complex porcine coronavirus [ transmissible gastroenteritis virus tgev] mpro constructed homology model sars coronavirus sars-cov m-pro structures reveal remarkable degree conservation substrate-binding sites supported recombinant sars-cov m-pro-mediated cleavage tgev mpro substrate molecular modeling suggests available rhinovirus 3cpro inhibitors may modified make useful treating sars 
